AbMask? & SynTac? Platform
Therapeutic Areas
Conditional Activation or Co-stimulation T-Cell Engager
"Conditional activation (AbMask? platform) or co-stimulation (SynTac? platform)" TCE
"inert in normal tissues but specifically activated in lesion tissues (e.g., tumor microenvironment)," enhances safety and broadens the therapeutic window.
AbMask? PRO-TCE
SynTac? Co-stimulatory TCE
PART 1
GenSci AbMask? PRO-TCE Platform
Next-generation prodrug technology: Using structural biology as an engine to reshape the therapeutic window for tumor immunotherapy
PART 2
SynTac? Co-stimulatory TCE Platform
Reconstructing Anti-tumor Immune Bridges to Empower Next-Generation Innovative Drug Development